REQUEST A DEMO
Total
USD $0.00
Search more companies

Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Lessors of Real Estate | Ambulatory Health Care Services | Offices of Physicians | All Other Miscellaneous Ambulatory Health Care Services | General Medical and Surgical Hospitals | Hotels (except Casino Hotels) and Motels
Full name: Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy Profile Updated: January 04, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy is based in Poland. The head office is in Warsaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was first established on December 30, 2002. It currently has a total number of 1,001 - 5,000 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 20.84% in 2024. Its’ total assets recorded a growth of 11.63%. The net profit margin of Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy increased by 0.21% in 2024.

Headquarters
Ul. Wilhelma Konrada Roentgena 5
Warsaw; Mazowieckie; Postal Code: 02-781

Contact Details: Purchase the Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy report to view the information.

Website: http://www.pib-nio.pl

Basic Information
Total Employees:
Purchase the Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy report to view the information.
Financial Auditors:
Purchase the Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy report to view the information.
Incorporation Date:
December 30, 2002
Key Executives
Purchase this report to view the information.
Director
Subsidiaries
Oncotransfer Sp. z o.o.
100%
Company Performance
Financial values in the chart are available after Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
20.84%
Total Operating Revenue
19.29%
Operating Profit
25.1%
EBITDA
15.82%
Net Profit/Loss for the Period
27.5%
Total Assets
11.63%
Total Equity
35.25%
Operating Profit Margin
0.15%
Net Profit Margin
0.21%
Return on Equity (ROE)
-1.59%
Debt / Equity
-11%
Quick Ratio
0.17%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?